{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T13:50:04Z","timestamp":1776952204118,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,5,15]],"date-time":"2015-05-15T00:00:00Z","timestamp":1431648000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12883-015-0338-9","type":"journal-article","created":{"date-parts":[[2015,5,13]],"date-time":"2015-05-13T19:25:39Z","timestamp":1431545139000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Accuracy and cutoff values of delayed heart to mediastinum ratio with 123I-metaiodobenzylguanidine cardiac scintigraphy for Lewy body disease diagnoses"],"prefix":"10.1186","volume":"15","author":[{"given":"Guillaume","family":"Lamotte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9my","family":"Morello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrien","family":"Lebasnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Agostini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles L.","family":"Defer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,15]]},"reference":[{"key":"338_CR1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1136\/jnnp.67.2.189","volume":"67","author":"S Orimo","year":"1999","unstructured":"Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. J Neurol Neurosurg Psychiatr. 1999;67:189\u201394.","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"338_CR2","first-page":"71","volume":"41","author":"H Takatsu","year":"2000","unstructured":"Takatsu H, Nishida H, Matsuo H, Watanabe S, Nagashima K, Wada H, et al. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG. J Nucl Med. 2000;41:71\u20137.","journal-title":"J Nucl Med"},{"key":"338_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1750-3639.2005.tb00097.x","volume":"15","author":"T Amino","year":"2005","unstructured":"Amino T, Orimo S, Itoh Y, Takahashi A, Uchihara T, Mizusawa H. Profound cardiac sympathetic denervation occurs in Parkinson disease. Brain Pathol. 2005;15:29\u201334.","journal-title":"Brain Pathol"},{"key":"338_CR4","doi-asserted-by":"publisher","first-page":"IV21","DOI":"10.1007\/s00415-007-4005-y","volume":"254","author":"S Orimo","year":"2007","unstructured":"Orimo S, Amino T, Uchihara T, Mori F, Kakita A, Wakabayashi K, et al. Decreased cardiac uptake of MIBG is a potential biomarker for the presence of Lewy bodies. J Neurol. 2007;254:IV21\u20138.","journal-title":"J Neurol"},{"key":"338_CR5","doi-asserted-by":"crossref","unstructured":"Spiegel J. diagnostic and pathophysiological impact of myocardial MIBG scintigraphy in parkinson's disease. Parkinsons Dis. 2010;2010.","DOI":"10.4061\/2010\/295346"},{"key":"338_CR6","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1002\/mds.23659","volume":"26","author":"AE King","year":"2011","unstructured":"King AE, Mintz J, Royall DR. Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders. Mov Disord. 2011;26:1218\u201324.","journal-title":"Mov Disord"},{"key":"338_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10286-011-0135-5","volume":"22","author":"G Treglia","year":"2012","unstructured":"Treglia G, Cason E, Stefanelli A, Cocciolillo F, Di Giuda D, Fagioli G, et al. MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis. Clin Auton Res. 2012;22:43\u201355.","journal-title":"Clin Auton Res"},{"key":"338_CR8","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.parkreldis.2012.01.009","volume":"18","author":"S Orimo","year":"2012","unstructured":"Orimo S, Suzuki M, Inaba A, Mizusawa H. 123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis. Parkinsonism Relat Disord. 2012;18:494\u2013500.","journal-title":"Parkinsonism Relat Disord"},{"key":"338_CR9","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1007\/s00259-010-1491-4","volume":"37","author":"A Flotats","year":"2010","unstructured":"Flotats A, Carri\u00f3 I, Agostini D, Le Guludec D, Marcassa C, Sch\u00e4fers M, et al. Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging. 2010;37:1802\u201312.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"338_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatr. 1992;55:181\u20134.","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"338_CR11","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65:1863\u201372.","journal-title":"Neurology"},{"key":"338_CR12","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S Gilman","year":"2008","unstructured":"Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008;71:670\u20136.","journal-title":"Neurology"},{"key":"338_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/WNL.47.1.1","volume":"47","author":"I Litvan","year":"1996","unstructured":"Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996;47:1\u20139.","journal-title":"Neurology"},{"key":"338_CR14","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","volume":"80","author":"MJ Armstrong","year":"2013","unstructured":"Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology. 2013;80:496\u2013503.","journal-title":"Neurology"},{"key":"338_CR15","first-page":"1326","volume":"17","author":"A Stefanelli","year":"2013","unstructured":"Stefanelli A, Treglia G, Bruno I, Rufini V, Giordano A. Pharmacological interference with 123I-metaiodobenzylguanidine: a limitation to developing cardiac innervation imaging in clinical practice? Eur Rev Med Pharmacol Sci. 2013;17:1326\u201333.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"338_CR16","first-page":"1062","volume":"42","author":"I Carri\u00f3","year":"2001","unstructured":"Carri\u00f3 I. Cardiac Neurotransmission Imaging*. J Nucl Med. 2001;42:1062\u201376.","journal-title":"J Nucl Med"},{"key":"338_CR17","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s00259-011-1754-8","volume":"38","author":"A Mux\u00ed","year":"2011","unstructured":"Mux\u00ed A, Paredes P, Navales I, Valldeoriola F, Gaig C, Lome\u00f1a F, et al. Diagnostic cutoff points for 123I-MIBG myocardial scintigraphy in a Caucasian population with Parkinson's disease. Eur J Nucl Med Mol Imaging. 2011;38:1139\u201346.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"338_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jns.2005.08.011","volume":"240","author":"M Suzuki","year":"2006","unstructured":"Suzuki M, Kurita A, Hashimoto M, Fukumitsu N, Abo M, Ito Y, et al. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease. J Neurol Sci. 2006;240:15\u20139.","journal-title":"J Neurol Sci"},{"key":"338_CR19","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1002\/mds.21499","volume":"22","author":"J Spiegel","year":"2007","unstructured":"Spiegel J, Hellwig D, Farmakis G, Jost WH, Samnick S, Fassbender K, et al. Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson's disease. Mov Disord. 2007;22:1004\u20138.","journal-title":"Mov Disord"},{"key":"338_CR20","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.jocn.2010.12.024","volume":"18","author":"EJ Chung","year":"2011","unstructured":"Chung EJ, Kim EG, Kim MS, Bae SK, Seog DH, Oh SJ, et al. Differences in myocardial sympathetic degeneration and the clinical features of the subtypes of Parkinson's disease. J Clin Neurosci. 2011;18:922\u20135.","journal-title":"J Clin Neurosci"},{"key":"338_CR21","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.3892\/mmr.2012.1104","volume":"6","author":"A Chiaravalloti","year":"2012","unstructured":"Chiaravalloti A, Stefani A, Tavolozza M, Pierantozzi M, Di Biagio D, Olivola E, et al. Different patterns of cardiac sympathetic denervation in tremor-type compared to akinetic-rigid-type Parkinson's disease: molecular imaging with 123I-MIBG. Mol Med Rep. 2012;6:1337\u201342.","journal-title":"Mol Med Rep"},{"key":"338_CR22","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.parkreldis.2009.01.008","volume":"15","author":"J-S Kim","year":"2009","unstructured":"Kim J-S, Shim Y-S, Song I-U, Yoo J-Y, Kim H-T, Kim Y-I, et al. Cardiac sympathetic denervation and its association with cognitive deficits in Parkinson's disease. Parkinsonism Relat Disord. 2009;15:706\u20138.","journal-title":"Parkinsonism Relat Disord"},{"key":"338_CR23","first-page":"1769","volume":"47","author":"DM Raffel","year":"2006","unstructured":"Raffel DM, Koeppe RA, Little R, Wang C-N, Liu S, Junck L, et al. PET measurement of cardiac and nigrostriatal denervation in Parkinsonian syndromes. J Nucl Med. 2006;47:1769\u201377.","journal-title":"J Nucl Med"},{"key":"338_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1874205X00701010001","volume":"1","author":"J Spiegel","year":"2007","unstructured":"Spiegel J, Hellwig D, Jost WH, Farmakis G, Samnick S, Fassbender K, et al. Cerebral and extracranial neurodegeneration are strongly coupled in PArkinson's disease. Open Neurol J. 2007;1:1\u20134.","journal-title":"Open Neurol J"},{"key":"338_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00259-009-1202-1","volume":"37","author":"K Ishibashi","year":"2010","unstructured":"Ishibashi K, Saito Y, Murayama S, Kanemaru K, Oda K, Ishiwata K, et al. Validation of cardiac (123)I-MIBG scintigraphy in patients with Parkinson's disease who were diagnosed with dopamine PET. Eur J Nucl Med Mol Imaging. 2010;37:3\u201311.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"338_CR26","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1468-1331.2008.02372.x","volume":"16","author":"H Sawada","year":"2009","unstructured":"Sawada H, Oeda T, Yamamoto K, Kitagawa N, Mizuta E, Hosokawa R, et al. Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease. Eur J Neurol. 2009;16:174\u201382.","journal-title":"Eur J Neurol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-015-0338-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-015-0338-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-015-0338-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-015-0338-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T22:03:34Z","timestamp":1566684214000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-015-0338-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,15]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["338"],"URL":"https:\/\/doi.org\/10.1186\/s12883-015-0338-9","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,15]]},"assertion":[{"value":"14 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"83"}}